These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8356888

  • 21. Serotonin activity in anorexia nervosa after long-term weight restoration: response to D-fenfluramine challenge.
    O'Dwyer AM, Lucey JV, Russell GF.
    Psychol Med; 1996 Mar; 26(2):353-9. PubMed ID: 8685291
    [Abstract] [Full Text] [Related]

  • 22. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL.
    Biol Psychiatry; 1991 Mar 01; 29(5):418-26. PubMed ID: 2018816
    [Abstract] [Full Text] [Related]

  • 23. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug 01; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

  • 24. The serotonin hypothesis of obsessive compulsive disorder.
    Barr LC, Goodman WK, Price LH.
    Int Clin Psychopharmacol; 1993 Nov 01; 8 Suppl 2():79-82. PubMed ID: 8201248
    [Abstract] [Full Text] [Related]

  • 25. Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.
    Bastani B, Nash JF, Meltzer HY.
    Arch Gen Psychiatry; 1990 Sep 01; 47(9):833-9. PubMed ID: 2203327
    [Abstract] [Full Text] [Related]

  • 26. Relationship between chronobiological thyrotropin and prolactin responses to protirelin (TRH) and suicidal behavior in depressed patients.
    Duval F, Mokrani MC, Erb A, Gonzalez Opera F, Calleja C, Paris V.
    Psychoneuroendocrinology; 2017 Nov 01; 85():100-109. PubMed ID: 28843902
    [Abstract] [Full Text] [Related]

  • 27. HPA axis disturbance in obsessive-compulsive disorder.
    Coryell WH, Black DW, Kelly MW, Noyes R.
    Psychiatry Res; 1989 Dec 01; 30(3):243-51. PubMed ID: 2694203
    [Abstract] [Full Text] [Related]

  • 28. 5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls.
    Lesch KP, Hoh A, Disselkamp-Tietze J, Wiesmann M, Osterheider M, Schulte HM.
    Arch Gen Psychiatry; 1991 Jun 01; 48(6):540-7. PubMed ID: 1674853
    [Abstract] [Full Text] [Related]

  • 29. Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin).
    Prange AJ, Loosen PT, Wilson IC, Meltzer HY, Fang VS.
    Arch Gen Psychiatry; 1979 Sep 01; 36(10):1086-93. PubMed ID: 112944
    [Abstract] [Full Text] [Related]

  • 30. Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment.
    Monteleone P, Catapano F, Di Martino S, Ferraro C, Maj M.
    Br J Psychiatry; 1997 Jun 01; 170():554-7. PubMed ID: 9330023
    [Abstract] [Full Text] [Related]

  • 31. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.
    Hollander E, Cohen LJ, DeCaria C, Saoud JB, Stein DJ, Cooper TB, Islam NN, Liebowitz MR, Klein DF.
    Biol Psychiatry; 1993 Sep 15; 34(6):407-13. PubMed ID: 8218609
    [Abstract] [Full Text] [Related]

  • 32. Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder.
    Fineberg NA, Cowen PJ, Kirk JW, Montgomery SA.
    J Affect Disord; 1994 Oct 15; 32(2):97-104. PubMed ID: 7829769
    [Abstract] [Full Text] [Related]

  • 33. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
    Duval F, Mokrani MC, Monreal J, Bailey P, Valdebenito M, Crocq MA, Macher JP.
    Psychoneuroendocrinology; 2003 Jul 15; 28(5):627-42. PubMed ID: 12727131
    [Abstract] [Full Text] [Related]

  • 34. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.
    Hadigan CM, Walsh BT, Buttinger C, Hollander E.
    Biol Psychiatry; 1995 Apr 15; 37(8):504-11. PubMed ID: 7619973
    [Abstract] [Full Text] [Related]

  • 35. Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder.
    Norman TR, Apostolopoulos M, Burrows GD, Judd FK.
    Int Clin Psychopharmacol; 1994 Apr 15; 9(2):89-94. PubMed ID: 8056999
    [Abstract] [Full Text] [Related]

  • 36. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ, Murray RM, O'Keane V.
    Neuropsychopharmacology; 1996 May 15; 14(5):349-54. PubMed ID: 8703303
    [Abstract] [Full Text] [Related]

  • 37. Fenfluramine and idiopathic pain: a serotonergic study in non-psychiatric patients with functional gastrointestinal disorder.
    Tanum L, Bråtveit-Johansen K, Malt UF.
    Scand J Gastroenterol; 1998 Jul 15; 33(7):684-90. PubMed ID: 9712230
    [Abstract] [Full Text] [Related]

  • 38. Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?
    Lucey JV, Butcher G, Clare AW, Dinan TG.
    Int Clin Psychopharmacol; 1992 Jul 15; 7(1):45-9. PubMed ID: 1624756
    [Abstract] [Full Text] [Related]

  • 39. Central serotoninergic stimulation by fenfluramine challenge does not affect plasma thyrotropin-stimulating hormone levels in man.
    Coccaro EF, Siever LJ, Kourides IA, Adan F, Campbell G, Davis KL.
    Neuroendocrinology; 1988 Apr 15; 47(4):273-6. PubMed ID: 3374753
    [Abstract] [Full Text] [Related]

  • 40. [Plasma LH, FSH, TSH, prolactin and cortisol during a combined test of pituitary reserve in prepubertal subjects with short stature].
    Esposito V, Bellastella A, D'Alessandro B, Santomassimo AM, Spagnoletti T, Cafaro MR.
    Boll Soc Ital Biol Sper; 1978 Dec 30; 54(24):2561-4. PubMed ID: 115486
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.